Clinical Trial

Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to evaluate the safety and efficacy of the Lifetech Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-07-20; most recent amendment 2025-07-25.
Status change: Not Yet Recruiting → Recruiting 2025-04-02
Trial Details
NCT Number NCT06520774
Lead Sponsor Lifetech Scientific (Shenzhen) Co., Ltd.
Collaborators: Second Xiangya Hospital of Central South University
Conditions Aortic Arch Aneurysm, Penetrating Aortic Ulcer
Enrollment 103 participants
Start Date 2024-05-30
Primary Completion 2027-07-30 (estimated)
Study Completion 2031-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-28